Please assess the completion status of the following clinical trial:

Trial Title: Celecoxib as a Post-tonsillectomy Pain Medication

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age at least 18 years~* Indication for tonsillectomy (patients undergoing a tonsillectomy as a portion of additional surgical procedures will not be included)~* Have the ability to understand and the willingness to sign a written informed consent document~Exclusion Criteria:~* History of bleeding disorders~* History of liver or kidney dysfunction~* History of allergy to sulfa containing medications~* History of lactose intolerance~* History of asthma, urticaria, or allergic-type reactions to aspirin or NSAIDs~* Women who are currently pregnant, nursing, or trying to conceive~* History of allergy or intolerance to acetaminophen or hydrocodone~* History of allergy to any COX-2 inhibitor, including celecoxib or rofecoxib.~* PT, PTT, hemoglobin, or hematocrit values that are outside of institutional limits.~* History of cardiovascular disease~* Patients currently taking celecoxib

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Celecoxib 200 mg tablets
- B (Type: PLACEBO_COMPARATOR): Placebo with same dosing schedule as the active comparator arm

Based on this trial design, predict the completion outcome and termination type (if applicable).